As of 2024-12-13, the Intrinsic Value of Surgical Science Sweden AB (SUS.ST) is
96.54 SEK. This SUS.ST valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 151.00 SEK, the upside of Surgical Science Sweden AB is
-36.10%.
The range of the Intrinsic Value is 64.47 - 258.13 SEK
96.54 SEK
Intrinsic Value
SUS.ST Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
a |
DCF (Growth 5y) |
64.47 - 258.13 |
96.54 |
-36.1% |
DCF (Growth 10y) |
132.35 - 594.29 |
209.05 |
38.4% |
DCF (EBITDA 5y) |
90.88 - 142.63 |
110.59 |
-26.8% |
DCF (EBITDA 10y) |
138.91 - 232.34 |
174.35 |
15.5% |
Fair Value |
94.73 - 94.73 |
94.73 |
-37.27% |
P/E |
81.69 - 129.56 |
102.27 |
-32.3% |
EV/EBITDA |
42.60 - 84.75 |
60.20 |
-60.1% |
EPV |
53.51 - 70.83 |
62.17 |
-58.8% |
DDM - Stable |
48.19 - 311.47 |
179.83 |
19.1% |
DDM - Multi |
123.42 - 622.89 |
206.31 |
36.6% |
SUS.ST Intrinsic Value - Key Valuation Metrics
Market Cap (mil) |
7,704.96 |
Beta |
0.68 |
Outstanding shares (mil) |
51.03 |
Enterprise Value (mil) |
7,038.63 |
Market risk premium |
5.10% |
Cost of Equity |
6.80% |
Cost of Debt |
5.00% |
WACC |
6.78% |